Abbott has acquired Rusian firm, Veropharm, at $305 mn
Singapore: Global pharmaceutical company, Abbott has acquired Russian firm Veropharm at $305 million with the strategy to establish manufacturing footprint in Russia through its existing and upcoming production facilities.
With this acquisition, Abbott also obtains a portfolio of medicines in women's health, central nervous system, cardiovascular and gastroenterology, and value additions in the profile of oncology and pharmaceutical R&D capabilities for Russia.
